There are signs that increased pharmaceutical research is helping to fuel drug manufacturing in Pennsylvania and Wisconsin.
According to a new report by the Pharmaceutical Research and Manufacturers of America (PhRMA), over 25 percent of the 901 cutting-edge biotechnology medicines that are being developed in the U.S are from Pennsylvania-based businesses.
PhRMA spokesman Jeff Trewhitt said Pennsylvania's success is mainly due to the large cluster of biotech companies and top-ranked research universities.
"Biopharmaceutical research companies in Pennsylvania are vitally important to not only the state's patients, but also the economy," Trewhitt added. "And with the prominent role they are playing in the development of cutting-edge biotechnology medicines, they are helping to advance science and, ultimately, patient care."
In 2008, the biopharmaceutical industry employed nearly 190,000 people in the state.
Meanwhile, in Wisconsin, Anteco Pharma, a contract manufacturer for the pharmaceutical industry in Lodi, recently broke ground on a $3.5 million facility, according to the Milwaukee Journal Sentinel.
The company said the new building is part of its five year plan to increase revenue tenfold and hire more than 60 new workers by 2016.